--- Page 0 ---
34699 Federal Register / Vol. 66, No. 126 / Friday, June 29, 2001 / Notices Dated: June 22, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –16334 Filed 6 –28–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerningindividuals associated with the grantapplications, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel,Demonstration and Education Research GrantApplications (R18s). Date: July 10 –11, 2001. Time: 12:30 pm to 1 pm. Agenda: To review and evaluate grant applications. Place: Chevy Chase Holiday Inn, Chevy Chase, MD 20815. Contact Person: Louise P Corman, Scientific Review Administrator, ReviewBranch, Room 7180, Division of ExtramuralAffairs, National Heart, Lung, and BloodInstitute, National Institutes of Health,Bethesda, MD 20892. This notice is being published less than 15 days prior to the meeting due to the timinglimitations imposed by the review andfunding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center forSleep Disorders Research; 93.837, Heart andVascular Diseases Research; 93.838, LungDiseases Research; 93.839, Blood Diseasesand Resources Research, National Institutesof Health, HHS) Dated: June 22, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –16335 Filed 6 –28–01; 8:45 am] BILLING CODE 4140 –01–MDEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The contract proposals andthe discussions could discloseconfidential trade secrets or commercialproperty such a patentable material, andpersonal information concerningindividuals associated with the contractproposals, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel,The Framingham Heart Study RFP –NHLBI – HC–01–02. Date: July 10, 2001. Time: 9 am to 11:30 am. Agenda: To review and evaluate contract proposals. Place: Chevy Chase Holiday Inn, Chevy Chase, MD 20815. Contact Person: Louise P. Corman, Scientific Review Administrator, ReviewBranch, Room 7180, Division of ExtramuralAffairs, National Heart, Lung, and BloodInstitute, National Institutes of Health,Bethesda, MD 20892 –7924. This notice is being published less than 15 days prior to the meeting due to the timinglimitations imposed by the review andfunding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center forSleep Disorders Research; 93.837, Heart andVascular Diseases Research; 93.838, LungDiseases Research; 93.839, Blood Diseasesand Resources Research, National Institutesof Health, HHS) Dated: June 22, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –16336 Filed 6 –28–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), notice is hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerningindividuals associated with the grantapplications, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel,Gene Transfer for Heart, Lung, and BloodDiseases. Date: July 18, 2001. Time: 1:30 pm to 2:30 pm. Agenda: To review and evaluate grant applications. Place: 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Anne P Clark, NIH, NHLBI, DEA, Review Branch, Rockledge II,6701 Rockledge Drive, Room 7202, Bethesda,MD 20892 –7924, 301/435 –0310. This notice is being published less than 15 days prior to the meeting due to the timinglimitations imposed by the review andfunding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center forSleep Disorders Research; 93.837, Heart andVascular Diseases Research; 93.838, LungDiseases Research; 93.839, Blood Diseasesand Resources Research, National Institutesof Health, HHS) Dated: June 22, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –16337 Filed 6 –28–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerning VerDate 11<MAY>2000 18:18 Jun 28, 2001 Jkt 194001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\29JNN1.SGM pfrm04 PsN: 29JNN1